Date | Shareholder name | Reason of Disclosure | Buy/Sell and Involved Shares |
Average Price per share | Current Holdings | % of Issued Shares |
12/11/2024 | 1201(L) | -36,000,000(L) | 364,000,000(L) | 30.34 | ||
12/11/2024 | 1201(L) | -36,000,000(L) | 364,000,000(L) | 30.34 | ||
12/11/2024 | 1201(L) | -36,000,000(L) | 364,000,000(L) | 30.34 | ||
12/11/2024 | 1201(L) | -36,000,000(L) | 364,000,000(L) | 30.34 | ||
12/07/2024 | Li Jincai | 11031(L) | +190,000(L) | 32,645,840(L) | 2.72 | |
12/07/2024 | Xi Xiaojie | 11031(L) | +136,744(L) | 10,136,744(L) | 0.85 | |
12/07/2024 | Zhang Jerry Jingwei | 11031(L) | +154,488(L) | 3,408,504(L) | 0.28 | |
13/12/2023 | WuXi Biologics (Cayman) Inc. | 1710(L) 1312(S) | -19,158,500(S) | 600,000,000(L) | 50.10 | |
01/12/2023 | Shi Ming | 1201(L) | -6(L) | HKD28.200(L) | 0(L) | 0.00 |
29/11/2023 | Shi Ming | 1302(L) | 6(L) | 6(L) | 0.00 | |
17/11/2023 | Chen Zhisheng | 1101(L) | +340,000(L) | HKD27.881(L) | 418,878(L) | 0.04 |
17/11/2023 | Chen Zhisheng | 1701(L) | +3,242(L) | 3,242(L) | 0.00 | |
17/11/2023 | Xi Xiaojie | 1701(L) | +10,000,000(L) | 10,000,000(L) | 0.85 | |
17/11/2023 | 1701(L) | 400,000,000(L) | 33.94 | |||
17/11/2023 | Li Jincai | 1701(L) | +32,455,840(L) | 32,455,840(L) | 2.75 | |
17/11/2023 | Chen Zhisheng | 1701(L) | +75,636(L) | 78,878(L) | 0.01 | |
17/11/2023 | 1701(L) | 400,000,000(L) | 33.94 | |||
17/11/2023 | Zhang Jerry Jingwei | 1701(L) | +3,254,016(L) | 3,254,016(L) | 0.28 | |
17/11/2023 | WuXi Biologics (Cayman) Inc. | 1701(L) 1313(S) | +600,000,000(L) +19,158,500(S) | 600,000,000(L) 19,158,500(S) | 50.91 1.63 | |
17/11/2023 | 1701(L) | 400,000,000(L) | 33.94 | |||
17/11/2023 | WuXi AppTec Co., Ltd. | 1701(L) | 400,000,000(L) | 33.94 | ||
17/11/2023 | Shi Ming | 1701(L) | +6(L) | 6(L) | 0.00 | |
1 |
Remark: | (L) - Long Position, (S) - Short Position, (P) Lending; |
Real time quote last updated: 23/12/2024 10:50 | |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |